R.E.J. Roach

1.2k total citations
15 papers, 680 citations indexed

About

R.E.J. Roach is a scholar working on Internal Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, R.E.J. Roach has authored 15 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Internal Medicine, 4 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in R.E.J. Roach's work include Venous Thromboembolism Diagnosis and Management (7 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Vascular anomalies and interventions (3 papers). R.E.J. Roach is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (7 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Vascular anomalies and interventions (3 papers). R.E.J. Roach collaborates with scholars based in Netherlands, Austria and India. R.E.J. Roach's co-authors include Willem M. Lijfering, Suzanne C. Cannegieter, Frits R. Rosendaal, Frans M. Helmerhorst, Olaf M. Dekkers, Theo Stijnen, Ale Algra, Saskia le Cessie, Astrid van Hylckama Vlieg and Rein Willemze and has published in prestigious journals such as Circulation, Blood and Cochrane Database of Systematic Reviews.

In The Last Decade

R.E.J. Roach

15 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.E.J. Roach Netherlands 9 262 183 158 125 120 15 680
Mouhamed Yazan Abou‐Ismail United States 10 186 0.7× 93 0.5× 212 1.3× 59 0.5× 52 0.4× 25 901
J. Kh. Khizroeva Russia 15 84 0.3× 90 0.5× 130 0.8× 62 0.5× 103 0.9× 146 773
Ayesha Zia United States 16 179 0.7× 100 0.5× 306 1.9× 50 0.4× 69 0.6× 62 851
Nathalie Trillot France 12 265 1.0× 188 1.0× 205 1.3× 31 0.2× 116 1.0× 35 1.1k
В. О. Бицадзе Russia 15 79 0.3× 89 0.5× 124 0.8× 67 0.5× 107 0.9× 148 748
Jan F M Egberts Netherlands 7 643 2.5× 493 2.7× 79 0.5× 80 0.6× 54 0.5× 12 965
Rachel Sam United Kingdom 13 383 1.5× 101 0.6× 56 0.4× 55 0.4× 40 0.3× 18 626
Louise Bowles United Kingdom 12 123 0.5× 91 0.5× 343 2.2× 44 0.4× 20 0.2× 18 804
İlmay Bilge Türkiye 17 22 0.1× 70 0.4× 85 0.5× 66 0.5× 48 0.4× 54 999
Madan Raj Aryal United States 17 160 0.6× 328 1.8× 99 0.6× 80 0.6× 51 0.4× 59 898

Countries citing papers authored by R.E.J. Roach

Since Specialization
Citations

This map shows the geographic impact of R.E.J. Roach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.E.J. Roach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.E.J. Roach more than expected).

Fields of papers citing papers by R.E.J. Roach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.E.J. Roach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.E.J. Roach. The network helps show where R.E.J. Roach may publish in the future.

Co-authorship network of co-authors of R.E.J. Roach

This figure shows the co-authorship network connecting the top 25 collaborators of R.E.J. Roach. A scholar is included among the top collaborators of R.E.J. Roach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.E.J. Roach. R.E.J. Roach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Roach, R.E.J., Remco van Doorn, Francisca T. de Bruı̈ne, Sandra M. Arend, & Leo G. Visser. (2018). A recurrent migratory swelling. The Lancet Infectious Diseases. 18(9). 1045–1045. 1 indexed citations
2.
Willemze, Rein, Laurien Daniëls, Karen J. Neelis, et al.. (2017). Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group. International Journal of Radiation Oncology*Biology*Physics. 99(5). 1279–1285. 14 indexed citations
3.
Roach, R.E.J., Remco van Doorn, Barbara Horváth, et al.. (2016). Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides. JAMA Dermatology. 152(9). 992–992. 101 indexed citations
4.
Roach, R.E.J., et al.. (2016). Allergic contact dermatitis caused by ultrasonic gel: is this possible for a hypoallergenic gel?. Contact Dermatitis. 75(5). 331–332. 1 indexed citations
5.
Roach, R.E.J., Willem M. Lijfering, Robert C. Tait, et al.. (2015). Sex difference in the risk of recurrent venous thrombosis: a detailed analysis in four European cohorts. Journal of Thrombosis and Haemostasis. 13(10). 1815–1822. 21 indexed citations
6.
Roach, R.E.J., Frans M. Helmerhorst, Willem M. Lijfering, et al.. (2015). Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database of Systematic Reviews. 2018(3). CD011054–CD011054. 177 indexed citations
7.
Roach, R.E.J., Suzanne C. Cannegieter, & Willem M. Lijfering. (2014). Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment. Journal of Thrombosis and Haemostasis. 12(10). 1593–1600. 110 indexed citations
8.
Roach, R.E.J., et al.. (2014). Thrombin generation and low-molecular-weight heparin prophylaxis in pregnant women with thrombophilia. Thrombosis and Haemostasis. 113(2). 283–289. 7 indexed citations
9.
Roach, R.E.J., Willem M. Lijfering, Linda E. Flinterman, Frits R. Rosendaal, & Suzanne C. Cannegieter. (2013). Increased risk of CVD after VT is determined by common etiologic factors. Blood. 121(24). 4948–4954. 27 indexed citations
10.
Roach, R.E.J., Bob Siegerink, & Willem M. Lijfering. (2013). [Case-crossover studies. Research into risk factors with the patient as his or her own control].. PubMed. 157(28). A5896–A5896. 2 indexed citations
11.
Roach, R.E.J., Willem M. Lijfering, Frits R. Rosendaal, Suzanne C. Cannegieter, & Saskia le Cessie. (2013). Sex Difference in Risk of Second but Not of First Venous Thrombosis. Circulation. 129(1). 51–56. 106 indexed citations
12.
Roach, R.E.J., Willem M. Lijfering, Astrid van Hylckama Vlieg, et al.. (2013). The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors. Blood. 122(26). 4264–4269. 35 indexed citations
13.
Roach, R.E.J., Willem M. Lijfering, Frans M. Helmerhorst, et al.. (2012). The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy. Journal of Thrombosis and Haemostasis. 11(1). 124–131. 69 indexed citations
14.
Roach, R.E.J., Bob Siegerink, Saskia le Cessie, et al.. (2012). Coffee consumption is associated with a reduced risk of venous thrombosis that is mediated through hemostatic factor levels. Journal of Thrombosis and Haemostasis. 10(12). 2519–2525. 8 indexed citations
15.
Eeden, Annelies E. van, R.E.J. Roach, Nynke Halbesma, & Friedo W. Dekker. (2012). [Drug-promoting advertisements in the Dutch Journal of Medicine and Pharmaceutical Weekly: not always evidence based].. PubMed. 156(1). A3999–A3999. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026